Articles Alert

Author: SIMON SILVER Department of Microbiology & Immunology University of Illinois Chicago The Luddites have mostly won during the 15 years of recombinant DNA research and debates. An FDA report concludes that bovine growth hormone presents no increased health risk. Yet the combination of building political bases and mounting irrational fear of genetic engineering means that we will probably continue to be protected from this unreal danger. Our students have questioning minds, so this compilat

Written bySimon Silver
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Author: SIMON SILVER
Department of Microbiology & Immunology University
of Illinois Chicago

The Luddites have mostly won during the 15 years of recombinant DNA research and debates. An FDA report concludes that bovine growth hormone presents no increased health risk. Yet the combination of building political bases and mounting irrational fear of genetic engineering means that we will probably continue to be protected from this unreal danger. Our students have questioning minds, so this compilation of studies (largely done by industry) is useful for education, even if the political process overrides scientific analysis.

J.C. Juskevich, C.G. Guyer, Bovine growth hormone: human food safety evaluation, Science, 249, 875-84, 24 August 1990. (Food and Drug Administration, Rockville, Md.)

Without direct structural information, mutational and gene-fusion analysis of membrane proteins is of limited power. That is the conclusion from the most thorough of such analyses on the best-studied membrane transport carrier.

H.R. Kaback, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies